title: [A CML case of 3-year survival after a myeloid blastic crisis treated with VP therapy and steroid pulse therapy].
authors.forename: S
authors.initials: S
authors.lastname: Suemaru
authors.forename: S
authors.initials: S
authors.lastname: Hirakawa
authors.forename: N
authors.initials: N
authors.lastname: Yamamoto
authors.forename: J
authors.initials: J
authors.lastname: Kageyama
authors.forename: Z
authors.initials: Z
authors.lastname: Ota
authors.forename: K
authors.initials: K
authors.lastname: Kitajima
authors.forename: K
authors.initials: K
authors.lastname: Sakamoto
authors.forename: J
authors.initials: J
authors.lastname: Kamura
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000473:pathology; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D011239:Prednisolone; D008775:Methylprednisolone